{
    "Trade/Device Name(s)": [
        "3test Supreme Glucose Monitoring System"
    ],
    "Submitter Information": "NEUERO ENGINEERING INC.",
    "510(k) Number": "K072905",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050224"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "April 2, 2008",
    "Summary Letter Received Date": "April 7, 2008",
    "Submission Date": "October 1, 2007",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Monitoring System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Capillary blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "3test Supreme Glucose Monitoring System"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for the 3test Supreme Glucose Monitoring System for quantitative measurement of glucose in whole blood using an electrochemical biosensor.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from the finger, for at-home or clinical use as an aid to monitor effectiveness of diabetes control.",
    "fda_folder": "Clinical Chemistry"
}